New Parkinson's Treatment Studied
University researchers have shown in the first large-scale study of a skin
patch to treat Parkinson's disease that the patch can be as effective as the
traditional oral medication.
"Many groups are exploring new ways of delivering Parkinson's drugs, and
this is the first to show success in a large study," said Karl Kieburtz,
professor of neurology and a lead investigator of the study.
The silicone patch carries a dopamine agonist, a type of drug commonly used
to treat the disease. The symptoms of Parkinson's, including tremors and stiff
and slow movements, are caused by the death of brain cells that produce dopamine,
a brain chemical that's key to controlling movement.
Maintained by University Public Relations
Please send your comments and suggestions to: